Editorial: Hwang's 'Guardian Angel' Owes Us an Explanation
By Chosun Ilbo,
Chosun Ilbo
| 01. 18. 2006
The presidential advisor for science and technology Park Ky-young received research grants of W150 million (US$150,000) and W100 million in 2001 and 2003 for studies on the ethics and social impact of bio-engineering from the disgraced cloning scientist Hwang Woo-suk. The 2001 research focused on the social impact of creating BSE-resistant cows, and the 2003 work on ethical guidelines and commercial use of bio-organs.
For a start, was the presidential aide, a botanist by training, charged with ethics research because the country is short on specialists in the field? More than 50 are listed as members of the Korean Bioethics Association. To say that her participation in some bioengineering forums as a representative of civic groups qualifies her for the research grants is stretching it.
A botany professor at Sunchon National University, Park joined the camp of President Roh Moo-hyun during the 2002 presidential election. In February 2003, she was a member of Roh's transition team assigned to an economics subcommittee. In June 2003, Park chaired the Future Strategy Subcommittee under the Policy Planning Committee, a presidential advisory body. In...
Related Articles
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...